Oaktree Acquisition Corp. III Life Sciences OACC
NASDAQ OACC
$10.78 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Oaktree Acquisition Corp. III Life Sciences (OACC) EBIT (2025 - 2026)

Updated

Oaktree Acquisition Corp. III Life Sciences' EBIT came in at -$261,958 for Q2 2026, compared with -$269,810 a year earlier.

Analysis

Oaktree Acquisition Corp. III Life Sciences (OACC) EBIT (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Oaktree Acquisition Corp. III Life Sciences reported EBIT of -$1.2 million; for FY2025, it came in at -$1.2 million.

  • Going back by year, EBIT was -$351,806 in FY2024.
  • The five-year range for quarterly EBIT is -$456,538 (Q1 2026) to -$225,579 (Q3 2025).
  • Business Quant data shows OACC's EBIT at -$456,538 (Q1 2026), -$255,496 (Q4 2025) and -$225,579 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -261,958.00
Mar 31, 2026 -456,538.00
Dec 31, 2025 -255,496.00
Sep 30, 2025 -225,579.00
Jun 30, 2025 -269,810.00
Mar 31, 2025 -444,802.00
API Access

Oaktree Acquisition Corp. III Life Sciences EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=OACC&period=max&api_key=YOUR_API_KEY